Episode Details

Back to Episodes
ThePrintPod: Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

ThePrintPod: Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

Episode 8678 Published 5 months ago
Description
Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.  
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us